Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

20 Jan 2026 07:00

RNS Number : 5104P
System1 Group PLC
20 January 2026
Β 

Β 

Β 

Β 

Β 

20 January 2026

Β 

System1 Group PLC (AIM: SYS1)

Β ("System1", or "the Company", or "the Group")

Trading Update - Growth in Platform Revenue in Q3 over first two quarters-

FY26 guidance maintained

Β 

System1 www.system1group.com today issues an update on trading for the quarter ended 31 December 2025 ("Q3 FY26", "Q3").

Β 

Platform revenue in Q3 was higher than the preceding two quarters, benefiting from increased Adtesting revenue in the UK and Europe which in H1 experienced reduced, but ongoing, spend by many clients due to the wider macroeconomic uncertainty.

Β 

Platform revenue was in line with the previous record Q3 FY25, and grew by 1% against that Q3 FY25 in constant currency. US platform revenue was in line with H1, and momentum in Innovation Platform revenue continued.

Β 

Non-platform revenue was Β£0.4m lower than in Q3 FY25 resulting in a 4% fall in reported total Group revenue (3% at constant currency) compared with last year's record Q3.

Β 

Revenue from new client wins grew by 10% in the first nine months of FY26 compared with the same period in FY25. These new clients contributed Β£7.4m of the Β£25.7m Platform Revenue in the year to date, a third of it in the US, and provide significant opportunities for future growth.

Β 

The Group held net cash of Β£8.3m at the end of December (Dec 2024: Β£10.2m) following the Β£1.4m dividend payment in October.

Β 

The Board maintains the FY26 guidance1 it provided on 23 September 2025 and in the interim results on 2 December 2025.

Β 

Β 

Β 

Β 

Revenue Β£ million - unaudited

Q3

Q3

Q3

YTD

YTD

YTD

FY26

FY25

% YoY

FY26

FY25

% YoY

Predict Your (data)

8.1

8.2

-1%

21.5

21.5

0%

Improve Your (data-led consultancy)

1.4

1.3

8%

4.2

4.7

-11%

Platform Revenue

9.5

9.5

0%

25.7

26.2

-2%

Other consultancy (non-platform)

0.3

0.7

-57%

1.2

2.3

-48%

Total Revenue

9.8

10.2

-4%

26.9

28.5

-6%

Β 

Commenting on the trading update, CEO James Gregory said: "Q3 saw a recovery in our revenue, particularly in UK & Europe, with many of our largest clients' Adtesting spend normalising after a reduced H1, providing some momentum for Q4. We therefore remain confident in maintaining our guidance for the year."

Β 

Further information on the Company can be found at www.system1group.com.

Β 

1 For the purpose of this announcement, the guidance provided in the 23 September 2025 announcement was for FY26 Revenue to be broadly in line with the Β£37m achieved in FY25, and Adjusted Profit beforeTaxation2 in a range between Β£2.0 to Β£2.5 million.

2 Adjusted Profit is Profit before Taxation excluding share-based payments

Β 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

Β 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)7467 990147

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

Β 

Canaccord Genuity Limited (Nominated Adviser & Broker)

Β 

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts / Harry Rees

Β 

Singer Capital Markets (Joint Broker)

Tel: +44 (0) 20 7496 3000Β 

James Moat / James Fischer / Sara Hale

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTUKSRRNKUAAUR
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.